U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07314333) titled 'A Trial to Assess How Centanafadine Interacts With Stimulants in the Body' on Dec. 18, 2025.
Brief Summary: This study will look at how centanafadine works when taken together with stimulant medicines in healthy adults, and whether combining them affects how the body responds.
Study Start Date: Feb. 03
Study Type: INTERVENTIONAL
Condition:
ADHD
Intervention:
DRUG: Centanafadine
Oral, QD XR capsules.
DRUG: Methylphenidate
Oral tablets.
DRUG: Lisdexamfetamine
Oral capsules
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Published by HT Digital Content Services wi...